Literature DB >> 2555124

The different contributions of prostaglandins (E1, E2, F2 alpha, D2) to the tone and neurogenic response of bovine iris sphincter muscle.

R Suzuki1, H Yoshino, S Kobayashi.   

Abstract

The function and sites of action of prostaglandins (PGs) vary in different animal species and tissues. In this study the influence of PGs (E1, E2, F2 alpha, D2) on muscle tone and nerve-mediated contraction was investigated in isolated bovine iris sphincter muscles. None of these PGs exogenously applied influenced the neuromuscular transmission. By contrast, after treatment with indomethacin, all PGs tested contracted the muscle much more than in the absence of indomethacin and under these conditions the PGs potentiated responses to cholinergic nerve stimulation. Their ED50 were (2.2 +/- 0.2) x 10(-7) M for PGE1, (6.7 +/- 0.3) x 10(-8) M for PGE2, and (7.3 +/- 0.4) x 10(-8) M for PGF2 alpha. PGE1 acted both on nerves and the muscle cell. PGE2 had its influence mostly via nerves. Whereas PGF2 alpha was less potent in the absence of indomethacin, PGF2 alpha had much more potent action primarily on nerves and partly on muscles after treatment with indomethacin. High concentrations of PGD2 had both pre- and post-junctional action with accompanying weak contraction of the muscle. Thus the degrees of pre- and post-junctional involvement were different from one another. There is a possibility that the application of these PGs alone masked the role of such endogenous agents. In order to understand and clarify the site and action of PGs, pretreatment with indomethacin may be useful in the iris muscle. In conclusion, PGs modulate cholinergic activity in the bovine iris sphincter muscles, as well as regulate the muscle tone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555124     DOI: 10.1007/BF00156703

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  23 in total

1.  The effects of prostaglandins on guinea-pig isolated intestine and their possible contribution to muscle activity and tone.

Authors:  A Bennett; K G Eley; H L Stockley
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  Further observations on the interaction of prostaglandin F2 alpha with cholinergic mechanisms in canine salivary glands.

Authors:  R A Hahn; P N Patil
Journal:  Eur J Pharmacol       Date:  1974-03       Impact factor: 4.432

3.  Prostaglandin-versus alpha-adrenoceptor-mediated control of sympathetic neurotransmitter secretion in guinea-pig isolated vas deferens.

Authors:  L Stjärne
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

4.  Pupil size and ocular pressure after sympathectomy and prostaglandin-catecholamine treatment.

Authors:  M B Waitzman
Journal:  Exp Eye Res       Date:  1970-10       Impact factor: 3.467

5.  Indomethacin, prostaglandin E2 and transmission at the frog neuromuscular junction.

Authors:  K S Madden; W Van der Kloot
Journal:  J Pharmacol Exp Ther       Date:  1985-02       Impact factor: 4.030

6.  Prostaglandin E2 and the bovine sphincter pupillae.

Authors:  J Posner
Journal:  Br J Pharmacol       Date:  1973-11       Impact factor: 8.739

7.  The effect of prostaglandins on the isolated internal muscles of the mammalian eye, including man.

Authors:  G W Alphen; P B Wilhelm; P W Elsenfeld
Journal:  Doc Ophthalmol       Date:  1977-02-28       Impact factor: 2.379

Review 8.  Prostaglandin and non-prostaglandin mediated breeakdown of the blood-aqueous barrier.

Authors:  K E Eakins
Journal:  Exp Eye Res       Date:  1977       Impact factor: 3.467

9.  The effect of intravitreal and topical prostaglandins on intraocular inflammation.

Authors:  P S Kulkarni; B D Srinivasan
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-09       Impact factor: 4.799

10.  Effects of indomethacin and prostaglandins on the dog iris sphincter and dilator muscles.

Authors:  T Yoshitomi; Y Ito
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.